CTNM - Contineum Therapeutics

CTNM is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.

Is anyone targeting this fund?

Yes - 3 large investors hold a stake, but none of them has asked for changes.

What this means for you

3 large investors own more than 5% of this company but have told the regulator they are not seeking changes. That is common for banks, brokers and index funds that hold shares for their clients.

Nothing is required of you. If an investor changes its mind, it must file a new notice within days, and it will show up here.

Email me if this changes

What happened, and when

  1. Oct 28, 2026

    Squadron Master Fund LP now owns 5.1%, as a passive investor.

    Original document →
  2. Oct 28, 2026

    Franklin Templeton now owns 5.2%, as a passive investor.

    Original document →
  3. Oct 22, 2026

    Trails Edge Capital Partners, LP now owns 5.1%, as a passive investor.

    Original document →
Details: all notices, events and fund facts
Notices from large investors about CTNM
DateInvestorStakeType of notice
Oct 28, 2026 Squadron Master Fund LP 5.1% Passive investor
Oct 28, 2026 Franklin Templeton 5.2% Updated notice
Oct 22, 2026 Trails Edge Capital Partners, LP 5.1% Passive investor

No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.

Run by
not filed yet
Fund family
not filed yet
Exchange
Nasdaq

See this fund's page at the SEC →

Download this fund's history (CSV)

Follow this fund in a news reader (feed)

Email me when something new is filed for CTNM

Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.